This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

4 Stocks Under $10 Moving Much Higher

Stocks in this article: PCONSPHCVMOTIV

CEL-SCI

CEL-SCI ( CVM) is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. This stock closed up 8.8% to 86 cents per share in Thursday's trading session.

Thursday's Range: $0.76-$0.86
52-Week Range: $0.75-$3.90
Thursday's Volume: 1.44 million
Three-Month Average Volume: 368,432

From a technical perspective, CVM ripped sharply higher here right above its recent low of 75 cents per share with heavy upside volume. This stock has been downtrending badly for the last two months and change, with shares plunging lower from its high of $2.75 to that low of 75 cents. During that downtrend, shares of CVM have been consistently making lower highs and lower lows, which is bearish technical price action. That move has pushed shares of CVM into oversold territory, since its current relative strength index reading is 24.96. Oversold can always get move oversold, but it's also an area where a stock can experience a powerful rebound higher from.

Traders should now look for long-biased trades in CVM as long as it's trending above its 52-week low of 75 cents and then once it sustains a move or close above Thursday's high of 86 cents to more near-term resistance levels at 88 cents to 95 cents per share with volume that hits near or above 368,432 shares. If we get that move soon, then CVM will set up to re-fill some of its previous gap down zone from earlier this month that started $1.35.

Nanosphere

Nanosphere ( NSPH) develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, which enables simple, low-cost and highly sensitive genomic and protein testing on a single platform. This stock closed up 5% to $2.04 a share in Thursday's trading session.

Thursday's Range: $1.91-$2.06
52-Week Range: $1.72-$4.49
Thursday's Volume: 535,000
Three-Month Average Volume: 635,089

From a technical perspective, NSPH spiked sharply higher here right above some near-term support at $1.88 and back above its 50-day moving average of $2.01 with decent upside volume. This stock has been trending sideways inside of a consolidation pattern for the last two months and change, with shares moving between $1.77 on the downside and just above $2.25 on the upside. This consolidation pattern is coming after shares of NSPH gapped down sharply back in August from just over $3 to $1.95. Shares of NSPH are now quickly moving within range of triggering a big breakout trade above the upper end of its recent sideways trading chart pattern. That trade will hit if NSPH manages to take out some near-term overhead resistance levels at $2.16 to $2.20, and then just above $2.25 with high volume.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs